Log in

Peter Lavoy Sells 3,000 Shares of Village Super Market, Inc. (NASDAQ:VLGEA) Stock

Posted on Tuesday, June 30th, 2020 by MarketBeat

Village Super Market, Inc. (NASDAQ:VLGEA) Director Peter Lavoy sold 3,000 shares of the firm's stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $25.63, for a total value of $76,890.00. Following the sale, the director now directly owns 38,828 shares of the company's stock, valued at $995,161.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of NASDAQ:VLGEA traded down $0.02 during midday trading on Tuesday, hitting $27.61. 661 shares of the stock were exchanged, compared to its average volume of 53,930. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.91 and a current ratio of 1.17. Village Super Market, Inc. has a 52-week low of $16.48 and a 52-week high of $28.71. The business's fifty day simple moving average is $24.63 and its two-hundred day simple moving average is $23.08. The company has a market capitalization of $388.33 million, a PE ratio of 17.71 and a beta of 0.13.

Village Super Market (NASDAQ:VLGEA) last announced its quarterly earnings data on Wednesday, June 3rd. The company reported $0.77 earnings per share (EPS) for the quarter. Village Super Market had a return on equity of 6.96% and a net margin of 1.30%. The business had revenue of $458.29 million during the quarter.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 23rd. Shareholders of record on Thursday, July 2nd will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 3.62%. The ex-dividend date is Wednesday, July 1st.

Separately, BidaskClub upgraded Village Super Market from a "sell" rating to a "hold" rating in a report on Thursday, June 11th.

A number of institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC increased its position in Village Super Market by 5.9% during the fourth quarter. Renaissance Technologies LLC now owns 690,900 shares of the company's stock worth $16,029,000 after buying an additional 38,400 shares during the last quarter. BlackRock Inc. grew its position in shares of Village Super Market by 5.3% in the first quarter. BlackRock Inc. now owns 617,327 shares of the company's stock valued at $15,175,000 after purchasing an additional 30,819 shares during the last quarter. Systematic Financial Management LP grew its position in shares of Village Super Market by 111.6% in the first quarter. Systematic Financial Management LP now owns 368,630 shares of the company's stock valued at $9,061,000 after purchasing an additional 194,445 shares during the last quarter. Deprince Race & Zollo Inc. grew its position in shares of Village Super Market by 1.7% in the first quarter. Deprince Race & Zollo Inc. now owns 284,338 shares of the company's stock valued at $6,989,000 after purchasing an additional 4,812 shares during the last quarter. Finally, State Street Corp grew its position in shares of Village Super Market by 45.4% in the first quarter. State Street Corp now owns 260,954 shares of the company's stock valued at $6,414,000 after purchasing an additional 81,425 shares during the last quarter. 44.37% of the stock is currently owned by hedge funds and other institutional investors.

About Village Super Market

Village Super Market, Inc operates a chain of supermarkets in the United States. Its stores feature specialty departments, such as an on-site bakery, an expanded delicatessen, various natural and organic foods, ethnic and international foods, prepared foods, and pharmacies. The company operates a chain of 30 ShopRite supermarkets, including 18 located in northern New Jersey, 8 located in southern New Jersey, 2 located in Maryland, 1 located in northeastern Pennsylvania, and 1 in Bronx, New York City.

Further Reading: What is the Book Value of a Share?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

15 Healthcare Stocks that Analysts Love

There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems and other healthcare stocks, it can be hard to identify which healthcare companies are going to outperform the market.

Fortunately, Wall Street's brightest minds have already done this for us. Every year, analyst issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same healthcare stock.

This slide show lists the 15 healthcare companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

View the "15 Healthcare Stocks that Analysts Love".

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.